Annals of Epidemiology
Volume 19, Issue 2 , Pages 103-111 , February 2009

Reproductive Factors and Risk of Pancreatic Cancer in Women: A Review of the Literature

  • Monika M. Wahi, MPH, CPH

      Affiliations

    • Military Performance Division, United States Army Research Institute of Environmental Medicine, Natick, MA
    • Department of Epidemiology and Biostatistics, University of South Florida College of Public Health, Tampa
    • Corresponding Author InformationAddress correspondence to: Monika M. Wahi, MPH, CPH, United States Army Research Institute of Environmental Medicine, Kansas St., Bldg. 42, Natick, MA 01760-5007. Tel.: (508) 233-5586; fax: (508) 233-4487.
    • ,
  • Nilay Shah, MD

      Affiliations

    • Department of Surgery, University of Pennsylvania School of Medicine, West Philadelphia
    • ,
  • Christopher E. Schrock, BS

      Affiliations

    • Department of Surgery, University of South Florida College of Medicine, Tampa
    • ,
  • Alexander S. Rosemurgy II, MD

      Affiliations

    • Department of Surgery, University of South Florida College of Medicine, Tampa
    • ,
  • Steven B. Goldin, MD, PhD

      Affiliations

    • Department of Surgery, University of South Florida College of Medicine, Tampa

Received 23 August 2008 ,Accepted 19 November 2008.

References 

  1. Jemal A, Siegel R, Ward E, Hao Y, Murray T, Thun MJ. Cancer Statistics, 2008. CA Cancer J Clin. 2008;58:71–96
  2. Greenlee RT, Hill-Harmon MB, Murray T, Thun M. Cancer Statistics, 2001. CA Cancer J Clin. 2001;51:15–36
  3. Lowenfels AB, Sullivan T, Fiorianti J, Maisonneuve P. The epidemiology and impact of pancreatic diseases in the United States. Curr Gastroenterol Rep. 2005;7:90–95
  4. Chiu BC, Lynch CF, Cerhan JR, Cantor KP. Cigarette smoking and risk of bladder, pancreas, kidney, and colorectal cancers in Iowa. Ann Epidemiol. 2001;11:28–37
  5. Bonelli L, Aste H, Bovo P, Cavallini G, Felder M, Gusmaroli R, et al. Exocrine pancreatic cancer, cigarette smoking, and diabetes mellitus: a case-control study in Northern Italy. Pancreas. 2003;27:143–149
  6. Annual smoking-attributable mortality, years of potential life lost, and economic costs—United States, 1995–1999. MMWR Morb Mortal Wkly Rep. 2002;51:300–303
  7. Eberle CA, Bracci PM, Holly EA. Anthropometric factors and pancreatic cancer in a population-based case-control study in the San Francisco Bay Area. Cancer Causes Control. 2005;16:1235–1244
  8. Moller H, Mellemgaard A, Lindvig K, Olsen JH. Obesity and cancer risk: a Danish record-linkage study. Eur J Cancer. 1994;30A:344–350
  9. Patel AV, Rodriguez C, Bernstein L, Chao A, Thun MJ, Calle EE. Obesity, recreational physical activity, and risk of pancreatic cancer in a large U.S. cohort. Cancer Epidemiol Biomarkers Prev. 2005;14:459–466
  10. Berrington de Gonzalez A, Sweetland S, Spencer E. A meta-analysis of obesity and the risk of pancreatic cancer. Br J Cancer. 2003;89:519–523
  11. Australian Institute of Health and Welfare (AIHW) & Australasian Association of Cancer Registries (AACR) . Cancer in Australia 2000. Canberra: AIHW; 2003;Rpt No. AIHW Cat. No. CAN 18
  12. Canadian Cancer Society/National Cancer Institute of Canada . Canadian Cancer Statistics 2006. Toronto: Canada; 2006;Rpt No. ISSN0835-2976
  13. Nagenthiraja K, Ewertz M, Engholm G, Storm HH. Incidence and mortality of pancreatic cancer in the Nordic countries 1971-2000. Acta Oncol. 2007;46:1064–1069
  14. Remontet L, Esteve J, Bouvier AM, Grosclaude P, Launoy G, Menegoz F, et al. Cancer incidence and mortality in France over the period 1978-2000. Rev Epidemiol Sante Publique. 2003;51:3–30
  15. Soliman AS, Zhang Q, Saleh T, Zarzour A, Selim M, Abdel-Fattah M, et al. Pancreatic cancer mortality in Egypt: comparison to the United States pancreatic cancer mortality rates. Cancer Detect Prev. 2006;30:473–479
  16. Cancer Research UK. UKPancreatic (Pancreas) Cancer Statistics. 2007. Available at: http://info.cancerresearchuk.org/cancerstats/types/pancreas/?a=5441. Accessed May 5, 2008.
  17. Qiu D, Kurosawa M, Lin Y, Inaba Y, Matsuba T, Kikuchi S, et al. Overview of the epidemiology of pancreatic cancer focusing on the JACC study. J Epidemiol. 2005;15(Suppl. 2):S157–S167
  18. National Cancer Institute. Surveillance Epidemiology and End Results Fast Stats. 2008. Available at: http://seer.cancer.gov/faststats/. Accessed May 5, 2008.
  19. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108
  20. Andren-Sandberg A, Hoem D, Backman PL. Other risk factors for pancreatic cancer: hormonal aspects. Ann Oncol. 1999;10(Suppl. 4):131–135
  21. Tobacco use among adults—United States, 2005. MMWR Morb Mortal Wkly Rep. 2006;55:1145–1148
  22. Fuchs CS, Colditz GA, Stampfer MJ, Giovannucci EL, Hunter DJ, Rimm EB, et al. A prospective study of cigarette smoking and the risk of pancreatic cancer. Arch Intern Med. 1996;156:2255–2260
  23. Greenway B, Iqbal MJ, Johnson PJ, Williams R. Oestrogen receptor proteins in malignant and fetal pancreas. Br Med J (Clin Res Ed). 1981;283:751–753
  24. Sandberg AA, Kirdani RY, Varkarakis MJ, Murphy GP. Estrogen receptor protein of pancreas. Steroids. 1973;22:259–271
  25. Sandberg AA, Rosenthal HE. Steroid receptors in exocrine glands: the pancreas and prostate. J Steroid Biochem. 1979;11:293–299
  26. Longnecker DS. Hormones and pancreatic cancer. Int J Pancreatol. 1991;9:81–86
  27. Pomerantz M, Manola J, Taplin ME, Bubley G, Inman M, Lowell J, et al. Phase I study of low dose and high dose conjugated estrogen for androgen independent prostate cancer. J Urol. 2007;177:2146–2150
  28. Torti FM. Hormonal therapy for prostate cancer. N Engl J Med. 1984;311:1313–1314
  29. Waxman J. Hormonal aspects of prostatic cancer: a review. J R Soc Med. 1985;78:129–135
  30. Martin MB, Stoica A. Insulin-like growth factor-I and estrogen interactions in breast cancer. J Nutr. 2002;132:3799S–3801S
  31. Slattery ML, Ballard-Barbash R, Edwards S, Caan BJ, Potter JD. Body mass index and colon cancer: an evaluation of the modifying effects of estrogen (United States). Cancer Causes Control. 2003;14:75–84
  32. Ohmura E, Okada M, Onoda N, Kamiya Y, Murakami H, Tsushima T, et al. Insulin-like growth factor I and transforming growth factor alpha as autocrine growth factors in human pancreatic cancer cell growth. Cancer Res. 1990;50:103–107
  33. Bergmann U, Funatomi H, Yokoyama M, Beger HG, Korc M. Insulin-like growth factor I overexpression in human pancreatic cancer: evidence for autocrine and paracrine roles. Cancer Res. 1995;55:2007–2011
  34. Krattenmacher R, Knauthe R, Parczyk K, Walker A, Hilgenfeldt U, Fritzemeier KH. Estrogen action on hepatic synthesis of angiotensinogen and IGF-I: direct and indirect estrogen effects. J Steroid Biochem Mol Biol. 1994;48:207–214
  35. Holmes MD, Pollak MN, Hankinson SE. Lifestyle correlates of plasma insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations. Cancer Epidemiol Biomarkers Prev. 2002;11:862–867
  36. Paassilta M, Karjalainen A, Kervinen K, Savolainen MJ, Heikkinen J, Backstrom AC, et al. Insulin-like growth factor binding protein-1 (IGFBP-1) and IGF-I during oral and transdermal estrogen replacement therapy: relation to lipoprotein(a) levels. Atherosclerosis. 2000;149:157–162
  37. Cano A, Castelo-Branco C, Tarin JJ. Effect of menopause and different combined estradiol-progestin regimens on basal and growth hormone-releasing hormone-stimulated serum growth hormone, insulin-like growth factor-1, insulin-like growth factor binding protein (IGFBP)-1, and IGFBP-3 levels. Fertil Steril. 1999;71:261–267
  38. Benz C, Hollander C, Miller B. Endocrine-responsive pancreatic carcinoma: steroid binding and cytotoxicity studies in human tumor cell lines. Cancer Res. 1986;46:2276–2281
  39. Keating JJ, Johnson PJ, Cochrane AM, Gazzard BG, Krasner N, Smith PM, et al. A prospective randomised controlled trial of tamoxifen and cyproterone acetate in pancreatic carcinoma. Br J Cancer. 1989;60:789–792
  40. Bueno de Mesquita HB, Maisonneuve P, Moerman CJ, Walker AM. Anthropometric and reproductive variables and exocrine carcinoma of the pancreas: a population-based case-control study in the Netherlands. Int J Cancer. 1992;52:24–29
  41. Cantor KP, Lynch CF, Johnson D. Reproductive factors and risk of brain, colon, and other malignancies in Iowa (United States). Cancer Causes Control. 1993;4:505–511
  42. Duell EJ, Holly EA. Reproductive and menstrual risk factors for pancreatic cancer: a population-based study of San Francisco Bay Area women. Am J Epidemiol. 2005;161:741–747
  43. Fernandez E, La Vecchia C, D'Avanzo B, Negri E. Menstrual and reproductive factors and pancreatic cancer risk in women. Int J Cancer. 1995;62:11–14
  44. Hanley AJ, Johnson KC, Villeneuve PJ, Mao Y. Physical activity, anthropometric factors and risk of pancreatic cancer: results from the Canadian Enhanced Cancer Surveillance System. Int J Cancer. 2001;94:140–147
  45. Ji BT, Hatch MC, Chow WH, McLaughlin JK, Dai Q, Howe GR, et al. Anthropometric and reproductive factors and the risk of pancreatic cancer: a case-control study in Shanghai, China. Int J Cancer. 1996;66:432–437
  46. Kalapothaki V, Tzonou A, Hsieh CC, Toupadaki N, Karakatsani A, Trichopoulos D. Tobacco, ethanol, coffee, pancreatitis, diabetes mellitus, and cholelithiasis as risk factors for pancreatic carcinoma. Cancer Causes Control. 1993;4:375–382
  47. Karlson BM, Wuu J, Hsieh CC, Lambe M, Ekbom A. Parity and the risk of pancreatic cancer: a nested case-control study. Int J Cancer. 1998;77:224–227
  48. Kreiger N, Lacroix J, Sloan M. Hormonal factors and pancreatic cancer in women. Ann Epidemiol. 2001;11:563–567
  49. Lo AC, Soliman AS, El-Ghawalby N, Abdel-Wahab M, Fathy O, Khaled HM, et al. Lifestyle, occupational, and reproductive factors in relation to pancreatic cancer risk. Pancreas. 2007;35:120–129
  50. Lin Y, Kikuchi S, Tamakoshi A, Kawamura T, Inaba Y, Kurosawa M, et al. Association of menstrual and reproductive factors with pancreatic cancer risk in women: Findings of the Japan Collaborative Cohort Study for Evaluation of Cancer Risk. J Gastroenterol. 2006;41:878–883
  51. Navarro Silvera SA, Miller AB, Rohan TE. Hormonal and reproductive factors and pancreatic cancer risk: a prospective cohort study. Pancreas. 2005;30:369–374
  52. Prizment AE, Anderson KE, Hong CP, Folsom AR. Pancreatic cancer incidence in relation to female reproductive factors: Iowa Women's Health Study. JOP. 2007;8:16–27
  53. Skinner HG, Michaud DS, Colditz GA, Giovannucci EL, Stampfer MJ, Willett WC, et al. Parity, reproductive factors, and the risk of pancreatic cancer in women. Cancer Epidemiol Biomarkers Prev. 2003;12:433–438
  54. Teras LR, Patel AV, Rodriguez C, Thun MJ, Calle EE. Parity, other reproductive factors, and risk of pancreatic cancer mortality in a large cohort of U.S. women (United States). Cancer Causes Control. 2005;16:1035–1040
  55. Casey PM, Cerhan JR, Pruthi S. Oral contraceptive use and risk of breast cancer. Mayo Clin Proc. 2008;83:86–90quiz 90–91
  56. Chambers J. R Software version 2.6.1. Vienna, Austria: The R foundation for Statistical Computing; 2008.
  57. Liu JM, Hankinson SE, Stampfer MJ, Rifai N, Willett WC, Ma J. Body iron stores and their determinants in healthy postmenopausal US women. Am J Clin Nutr. 2003;78:1160–1167
  58. Milman N, Byg KE, Ovesen L. Iron status in Danes 1994. II: Prevalence of iron deficiency and iron overload in 1319 Danish women aged 40-70 years. Influence of blood donation, alcohol intake and iron supplementation. Ann Hematol. 2000;79:612–621
  59. Weinberg ED. The role of iron in cancer. Eur J Cancer Prev. 1996;5:19–36
  60. Friedman GD, van den Eeden SK. Risk factors for pancreatic cancer: an exploratory study. Int J Epidemiol. 1993;22:30–37
  61. Silverman DT, Swanson CA, Gridley G, Wacholder S, Greenberg RS, Brown LM, et al. Dietary and nutritional factors and pancreatic cancer: a case-control study based on direct interviews. J Natl Cancer Inst. 1998;90:1710–1719
  62. Brett KM. Can hysterectomy be considered a risk factor for cardiovascular disease?. Circulation. 2005;111:1456–1458
  63. Prentice RL. The population science research agenda and the Women's Health Initiative presented at Joint Statistical Meeting 2008, Denver, CO, August 6, 2008.
  64. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002;288:321–333
  65. Kapoor D, Jones TH. Smoking and hormones in health and endocrine disorders. Eur J Endocrinol. 2005;152:491–499

PII: S1047-2797(08)00352-9

doi: 10.1016/j.annepidem.2008.11.003

Annals of Epidemiology
Volume 19, Issue 2 , Pages 103-111 , February 2009

Article Tools